Skip to main content
. 2019 Oct 31;36(4):343–348. doi: 10.1055/s-0039-1696648

Fig. 3.

Fig. 3

( a ) Baseline MRI of a 62-year-old male with a 5-cm tumor in hepatic segment 7. ( b ) Volumetric assessment showing baseline FLR = 31.7%. ( c ) One-month MRI follow-up post Y90 showing complete response of tumor by mRECIST criteria. ( d ) Six-month MRI follow-up showing continuous complete response of the treated tumor that is concurrent with right lobe atrophy and left lobe hypertrophy. ( e ) Volumetric assessment showing 6-month FLR = 43%. ( f ) One-month MRI follow-up scan postresection showing marked hypertrophy of the left liver lobe (liver remnant).